GLP-1R

CAT # Izina ryibicuruzwa Ibisobanuro
CPD100594 TT15 TT15 ni agoniste wa GLP-1R.
CPD100593 VU0453379 VU0453379 ni glucagon ya CNS-yinjira muri peptide ya peptide 1 yakira (GLP-1R) moderi nziza ya allosteric modulator (PAM)
CPD100592 PF-06882961 PF-06882961 ni agoniste ikomeye, mu kanwa bioavailable agonist ya glucagon imeze nka peptide-1 yakira (GLP-1R).
CPD100591 PF-06372222 PF-06372222 ni molekile ntoya ya allosteric modulator (NAM) ya glucagon reseptor (GCGR). Antagonistes ya GCGR irashobora gufasha mukuvura diyabete yo mu bwoko bwa 2 kuko igenga plasma glucose igabanya cyangwa igabanya umuvuduko wa glucose ya hepatike yerekana umwijima, imitsi yoroshye yo munda, impyiko, ubwonko, hamwe na tipusi ya adipose. PF-06372222 nayo irwanya glucagon imeze nka peptide-1 yakira reseptor GLP-1R, ibuza gusohora glucagon hamwe na glucose iterwa na glucose kandi ishobora no kugira uruhare mukurekura imisemburo itera guhangayika bikabije kandi bidakira no guhangayika. Muguhindura nabi GLP-1R, PF-06372222 irashobora kuvura indwara ya diyabete yo mu bwoko bwa 2 hamwe no guhangayika no guhangayika.
CPD100590 NNC0640 NNC0640 ni moderi mbi ya allosteric modulator ya glucagon imeze nka peptide-1 yakira (GLP-1R).
CPD100589 HTL26119 HTL26119 nigitabo gishya cya allosteric antagonist ya glucagon imeze nka peptide-1 yakira (GLP-1R).
Ese?

Twandikire

Itohoza

Amakuru agezweho

  • Inzira 7 Zambere Mubushakashatsi bwa Farumasi Muri 2018

    Inzira 7 Zambere Mubushakashatsi bwa Farumasi I ...

    Kuba uri munsi yigitutu cyinshi kugirango duhatane mubibazo bitoroshye byubukungu n’ikoranabuhanga, uruganda rukora imiti n’ibinyabuzima rugomba guhora rushya muri gahunda zabo za R&D kugirango rukomeze imbere ...

  • ARS-1620: Kanseri nshya ya KRAS-mutant

    ARS-1620: Inhibitor nshya itanga ikizere kuri K ...

    Nk’uko ubushakashatsi bwasohotse mu Kagari bubitangaza, abashakashatsi bakoze inzitizi yihariye ya KRASG12C yitwa ARS-1602 itera ibibyimba gusubira mu mbeba. "Ubu bushakashatsi butanga muri vivo ibimenyetso byerekana ko mutant KRAS ishobora kuba ...

  • AstraZeneca yakira imbaraga zo kugenzura imiti ya oncology

    AstraZeneca yakira imbaraga zo kugenzura ...

    Ku wa kabiri, AstraZeneca yakiriye inshuro ebyiri mu nshingano zayo za oncology, nyuma y’uko abagenzuzi b’Amerika n’Uburayi bemeye gutanga amabwiriza agenga imiti y’ibiyobyabwenge, intambwe yambere yo gutsindira kwemerwa niyi miti. ...

Ikiganiro cya WhatsApp Kumurongo!